All HC Readers,
Please email the ASX and complain that Biota failed to inform the ASX of this very important policy change of stocking 5:50 Tamiflu/Relenza.
The email address is: [email protected]
If you look at the sp chart the sp rose from sharply from $2.51 from the date of the HHS document 25 September to $3.33 on 19 October before traders swarmed it down to $2.88 to an uninformed market probably with the advantage of the policy news.
Relenza is Biota's single most important income and yet management is oblivious to such important public news affecting the most important income.
Are they waiting for the AGM to announce this news to make shareholders happy at the meeting?
What a useless bunch of fools.
- Forums
- ASX - By Stock
- BTA
- usa ordering 50 % relenza and lani iv news
usa ordering 50 % relenza and lani iv news, page-5
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online